1、 PAGER C K.Expectations and outcomes in cataract surgery:A prospective test of 2 models of satisfaction[J].Arch Ophthalmol,2004,122(12):1788-1792. PAGER C K.Expectations and outcomes in cataract surgery:A prospective test of 2 models of satisfaction[J].Arch Ophthalmol,2004,122(12):1788-1792.
2、 ADDISU Z,SOLOMON B.Patients’ preoperative expectation and outcome of cataract surgery at Jimma university specialized hospital-department of ophthalmology[J].Ethiop J Health Sci,2011,21(1):47-55. ADDISU Z,SOLOMON B.Patients’ preoperative expectation and outcome of cataract surgery at Jimma university specialized hospital-department of ophthalmology[J].Ethiop J Health Sci,2011,21(1):47-55.
3、 DAY A C,DONACHIE P H,SPARROW J M,et al.The royal college of ophthalmologists’ national ophthalmology database study of cataract surgery:Report 1,visual outcomes and complications[J].Eye(Lond),2015,29(4):552-560. DAY A C,DONACHIE P H,SPARROW J M,et al.The royal college of ophthalmologists’ national ophthalmology database study of cataract surgery:Report 1,visual outcomes and complications[J].Eye(Lond),2015,29(4):552-560.
4、 BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:a systematic analysis[J].Lancet Glob Health,2013,1(6):e339-349. BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:a systematic analysis[J].Lancet Glob Health,2013,1(6):e339-349.
5、 BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:A systematic analysis[J].Lancet Glob Health,2013,1(6):e339-e349. BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:A systematic analysis[J].Lancet Glob Health,2013,1(6):e339-e349.
6、 LI M,GONG L,CHAPIN W J,et al.Assessment of vision-related quality of life in dry eye patient[J].Invest Ophthalmol Vis Sci,2012,53(9):5722-5727. LI M,GONG L,CHAPIN W J,et al.Assessment of vision-related quality of life in dry eye patient[J].Invest Ophthalmol Vis Sci,2012,53(9):5722-5727.
7、 POUYEH B,VITERI E,FEUER W,et al.Impact of ocular surface symptoms on quality of life in a United States veterans’ affairs population[J].Am J Ophthalmol,2012,153(6):1061-1066,e3. POUYEH B,VITERI E,FEUER W,et al.Impact of ocular surface symptoms on quality of life in a United States veterans’ affairs population[J].Am J Ophthalmol,2012,153(6):1061-1066,e3.
8、 MILJANOVI? B,DANA R,SULLIVAN D A,et al.Impact of dry eye syndrome on vision-related quality of life[J].Am J Ophthalmol,2007,143(3):409-415. MILJANOVI? B,DANA R,SULLIVAN D A,et al.Impact of dry eye syndrome on vision-related quality of life[J].Am J Ophthalmol,2007,143(3):409-415.
9、 BOWEN R C,KOEPPEL J N,CHRISTENSEN C D,et al.The most common causes of eye pain at 2 tertiary ophthalmology and neurology clinics[J].J Neuroophthalmol,2018,38(3):320-327. BOWEN R C,KOEPPEL J N,CHRISTENSEN C D,et al.The most common causes of eye pain at 2 tertiary ophthalmology and neurology clinics[J].J Neuroophthalmol,2018,38(3):320-327.
10、 BOURGES J L.Corneal dystrophies[J].J Fr Ophtalmol,2017,40(6):e177-e192. BOURGES J L.Corneal dystrophies[J].J Fr Ophtalmol,2017,40(6):e177-e192.
11、 MILLER D D,HASAN S A,SIMMONS N L,et al.Recurrent corneal erosion:A comprehensive review[J].Clin Ophthalmol,2019(13):325-335. MILLER D D,HASAN S A,SIMMONS N L,et al.Recurrent corneal erosion:A comprehensive review[J].Clin Ophthalmol,2019(13):325-335.
12、 MOHAMMADPOUR M,MALEKI S,KHORRAMI-NEJAD M.The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery:A randomized clinical trial[J].Eur J Ophthalmol,2020,30(6):1313-1319. MOHAMMADPOUR M,MALEKI S,KHORRAMI-NEJAD M.The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery:A randomized clinical trial[J].Eur J Ophthalmol,2020,30(6):1313-1319.
13、 ERGUN S B,SARIBAS G S,YARAYICI S,et al.Comparison of efficacy and safety of two tea tree oil-based formulations in patients with chronic blepharitis:A double-blinded randomized clinical trial[J].Ocul Immunol Inlflamm,2020,28(6):888-897. ERGUN S B,SARIBAS G S,YARAYICI S,et al.Comparison of efficacy and safety of two tea tree oil-based formulations in patients with chronic blepharitis:A double-blinded randomized clinical trial[J].Ocul Immunol Inlflamm,2020,28(6):888-897.
14、 GIANNACCARE G,PELLEGRINI M,SEBASTIANI S,et al.Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease:A meta-analysis of randomized clinical trials[J].Cornea,2019,38(5):565-573. GIANNACCARE G,PELLEGRINI M,SEBASTIANI S,et al.Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease:A meta-analysis of randomized clinical trials[J].Cornea,2019,38(5):565-573.
15、 SZAKATS I,SEBESTYEN M,TOTH E,et al.Dry eye symptoms,patient-reported visual functioning,and health anxiety influencing patient satisfaction after cataract surgery[J].Current Eye Res,2017,42(6):832-836. SZAKATS I,SEBESTYEN M,TOTH E,et al.Dry eye symptoms,patient-reported visual functioning,and health anxiety influencing patient satisfaction after cataract surgery[J].Current Eye Res,2017,42(6):832-836.
16、 IPEK T,HANGA M P,HARTWIG A,et al.Dry eye following cataract surgery:The effect of light exposure using an in-vitro model[J].Cont Lens Ant Eye,2018,41(1):128-131. IPEK T,HANGA M P,HARTWIG A,et al.Dry eye following cataract surgery:The effect of light exposure using an in-vitro model[J].Cont Lens Ant Eye,2018,41(1):128-131.
17、 CHO Y K,KIM M S.Dry eye after cataract surgery and associated intraoperative risk factors[J].Korean J Ophthalmol,2009,3(2):65-73. CHO Y K,KIM M S.Dry eye after cataract surgery and associated intraoperative risk factors[J].Korean J Ophthalmol,2009,3(2):65-73.
18、 SAJNANI R,RAIA S,GIBBONS A,et al.Epidemiology of persistent postsurgical pain manifesting as dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(12):1535-1541. SAJNANI R,RAIA S,GIBBONS A,et al.Epidemiology of persistent postsurgical pain manifesting as dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(12):1535-1541.
19、 HWANG H B,KIM H S.Phototoxic effects of an operating microscope on the ocular surface and tear film[J].Cornea,2014,33(1):82-90. HWANG H B,KIM H S.Phototoxic effects of an operating microscope on the ocular surface and tear film[J].Cornea,2014,33(1):82-90.
20、 HE Y,LI J,ZHU J,et al.The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea:The results of a consort-compliant randomized controlled trial[J].Medicine(Baltimore),2017,96(50):e8940. HE Y,LI J,ZHU J,et al.The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea:The results of a consort-compliant randomized controlled trial[J].Medicine(Baltimore),2017,96(50):e8940.
21、 YOON D Y,KIM J H,JEON H S,et al.Evaluation of the protective effect of an ophthalmic viscosurgical device on the ocular surface in dry eye patients during cataract surgery[J].Korean J Ophthalmol,2019,33(5):467-474. YOON D Y,KIM J H,JEON H S,et al.Evaluation of the protective effect of an ophthalmic viscosurgical device on the ocular surface in dry eye patients during cataract surgery[J].Korean J Ophthalmol,2019,33(5):467-474.
22、 YUSUFU M,LIU X,ZHENG T,et al.Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients[J].Int Ophthalmol,2018,38(3):1261-1273. YUSUFU M,LIU X,ZHENG T,et al.Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients[J].Int Ophthalmol,2018,38(3):1261-1273.
23、 MIURA M,INOMATA T,NOJIRI S,et al.Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery:a protocol for a single-centre,randomised controlled trial[J].BMJ Open,2022,12(1):e052488. MIURA M,INOMATA T,NOJIRI S,et al.Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery:a protocol for a single-centre,randomised controlled trial[J].BMJ Open,2022,12(1):e052488.
24、 FOGAGNOLO P,FAVUZZA E,MARCHINA D,et al.New therapeutic strategy and innovative lubricating ophthalmic solution in minimizing dry eye disease associated with cataract surgery:A randomized prospective study[J].Adv Ther,2020,37(4):1664-1674. FOGAGNOLO P,FAVUZZA E,MARCHINA D,et al.New therapeutic strategy and innovative lubricating ophthalmic solution in minimizing dry eye disease associated with cataract surgery:A randomized prospective study[J].Adv Ther,2020,37(4):1664-1674.
25、 JEE D,PARK M,LEE H J,et al.Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome[J].J Cataract Refract Surg,2015,41(4):756-763. JEE D,PARK M,LEE H J,et al.Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome[J].J Cataract Refract Surg,2015,41(4):756-763.
26、 DART J.Corneal toxicity:the epithelium and stroma in iatrogenic and factitious disease[J].Eye(Lond),2003,17(8):886-892. DART J.Corneal toxicity:the epithelium and stroma in iatrogenic and factitious disease[J].Eye(Lond),2003,17(8):886-892.
27、 EPSTEIN S P,AHDOOT M,MARCUS E,et al.Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells[J].J Ocul Pharmacol Ther,2009,25(2):113-119. EPSTEIN S P,AHDOOT M,MARCUS E,et al.Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells[J].J Ocul Pharmacol Ther,2009,25(2):113-119.
28、 ROSENWASSER G O.Complications of topical ocular anesthetics[J].Int Opthalmol Clin,1989,29(3):153-158. ROSENWASSER G O.Complications of topical ocular anesthetics[J].Int Opthalmol Clin,1989,29(3):153-158.
29、 MOREIRA L B,KASETSUWAN N,SANCHEZ D,et al.Toxicity of topical anesthetic agents to human keratocytes in vivo[J].J Cataract Refract Surg,1999,25(7):975-980. MOREIRA L B,KASETSUWAN N,SANCHEZ D,et al.Toxicity of topical anesthetic agents to human keratocytes in vivo[J].J Cataract Refract Surg,1999,25(7):975-980.
30、 YANAI R,YAMADA N,UEDA K,et al.Evaluation of povidone-iodine as a disinfectant solution for contact lenses:Antimicrobial activity and cytotoxicity for corneal epithelial cells[J].Cont Lens Anterior Eye,2006,29(2):85-91. YANAI R,YAMADA N,UEDA K,et al.Evaluation of povidone-iodine as a disinfectant solution for contact lenses:Antimicrobial activity and cytotoxicity for corneal epithelial cells[J].Cont Lens Anterior Eye,2006,29(2):85-91.
31、 PELS E,VRENSEN G F.Microbial decontamination of human donor eyes with povidone-iodine:Penetration,toxicity,and effectiveness[J].Br J Ophthalmol,1999,83(9):1019-1026. PELS E,VRENSEN G F.Microbial decontamination of human donor eyes with povidone-iodine:Penetration,toxicity,and effectiveness[J].Br J Ophthalmol,1999,83(9):1019-1026.
32、 EGUCHI A,INOMATA T,NAKAMURA M,et al.Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan:large-scale crowdsourced research using DryEyeRhythm application[J].Jpn J Ophthalmol,2021,65(2):271-281. EGUCHI A,INOMATA T,NAKAMURA M,et al.Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan:large-scale crowdsourced research using DryEyeRhythm application[J].Jpn J Ophthalmol,2021,65(2):271-281.
33、 CHHABRA S,JERKINS J H,CONTO J E,et al.Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease[J].Leuk Lymphoma,2020,61(4):869-874. CHHABRA S,JERKINS J H,CONTO J E,et al.Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease[J].Leuk Lymphoma,2020,61(4):869-874.
34、 HABER S L,BENSON V,BUCKWAY C J,et al.Lifitegrast:a novel drug for patients with dry eye disease[J].Ther Adv Ophthalmol,2019(11):2515841419870366. HABER S L,BENSON V,BUCKWAY C J,et al.Lifitegrast:a novel drug for patients with dry eye disease[J].Ther Adv Ophthalmol,2019(11):2515841419870366.
35、 TONG A Y,PASSI S F,GUPTA P K.Clinical outcomes of lifitegrast 5% ophthalmic solution in the treatment of dry eye disease[J].Eye Contact Lens,2020,46Suppl1:S20-S24. TONG A Y,PASSI S F,GUPTA P K.Clinical outcomes of lifitegrast 5% ophthalmic solution in the treatment of dry eye disease[J].Eye Contact Lens,2020,46Suppl1:S20-S24.
36、 IGARASHI T,KOBAYASHI M,YAGUCHI C,et al.Efficacy of rebamipide instillation for contact lens discomfort with dry eye[J].Eye Contact Lens,2018,44Suppl 2(2):S137-S142. IGARASHI T,KOBAYASHI M,YAGUCHI C,et al.Efficacy of rebamipide instillation for contact lens discomfort with dry eye[J].Eye Contact Lens,2018,44Suppl 2(2):S137-S142.
37、 JUN I,CHOI S,LEE G Y,et al.Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery:A randomized clinical trial[J].Sci Report,2019,9(1):12659. JUN I,CHOI S,LEE G Y,et al.Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery:A randomized clinical trial[J].Sci Report,2019,9(1):12659.
38、 CUI L,LI Y,LEE H S,et al.Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye[J].Int Ophthalmol,2018,38(5):2021-2030. CUI L,LI Y,LEE H S,et al.Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye[J].Int Ophthalmol,2018,38(5):2021-2030.
39、 WATANABE H.Medical treatment for dry eye in Japan[J].Invest Ophthalmol Vis Sci,2018,59(14):DES116-DES120. WATANABE H.Medical treatment for dry eye in Japan[J].Invest Ophthalmol Vis Sci,2018,59(14):DES116-DES120.
40、 HORI Y.Secreted mucins on the ocular surface[J].Invest Ophthalmol Vis Sci,2018,59(14):DES151-DES156. HORI Y.Secreted mucins on the ocular surface[J].Invest Ophthalmol Vis Sci,2018,59(14):DES151-DES156.
41、 CARETTI L,LA GLORIA VALERIO A,PIERMAROCCHI R,et al.Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery[J].Clin Ophthalmol,2019(13):1157-1163. CARETTI L,LA GLORIA VALERIO A,PIERMAROCCHI R,et al.Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery[J].Clin Ophthalmol,2019(13):1157-1163.
42、 GANESH S,BRAR S,BAGARE S N.Topical cyclosporine(0.05%)for management of dry eyes in patients undergoing cataract surgery-a comparative study[J].Open Ophthalmol J,2019,13(1):3442. GANESH S,BRAR S,BAGARE S N.Topical cyclosporine(0.05%)for management of dry eyes in patients undergoing cataract surgery-a comparative study[J].Open Ophthalmol J,2019,13(1):3442.
43、 YILDIZ E,YENEREL N M,TURAN-YARDIMCI A,et al.Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis[J].J Ocul Pharmacol Ther,2018,34(4):365-372. YILDIZ E,YENEREL N M,TURAN-YARDIMCI A,et al.Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis[J].J Ocul Pharmacol Ther,2018,34(4):365-372.
44、 APT L,ISENBERG S J,YOSHIMORI R,et al.Outpatient topical use of povidone-iodine in preparing the eye for surgery[J].Ophthalmology,1989,96(3):289-292. APT L,ISENBERG S J,YOSHIMORI R,et al.Outpatient topical use of povidone-iodine in preparing the eye for surgery[J].Ophthalmology,1989,96(3):289-292.
45、 LI X M,HU L,HU J,et al.Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery[J].Cornea,2007,26(9 Suppl.1):S16-S20. LI X M,HU L,HU J,et al.Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery[J].Cornea,2007,26(9 Suppl.1):S16-S20.
46、 SHIVITZ I A,ARROWSMITH P N.Corneal sensitivity after radial keratotomy[J].Ophthalmology,1988,95(6):827-832. SHIVITZ I A,ARROWSMITH P N.Corneal sensitivity after radial keratotomy[J].Ophthalmology,1988,95(6):827-832.
47、 HOVANESIAN J A.The effect of lifitegrast on refractive accuracy,higher order aberrations,and symptoms in dry eye patients undergoing cataract surgery.In:Presented at American Society of Cataract and Refractive Surgery annual meeting,San Diego,CA,3-7 May 2019. HOVANESIAN J A.The effect of lifitegrast on refractive accuracy,higher order aberrations,and symptoms in dry eye patients undergoing cataract surgery.In:Presented at American Society of Cataract and Refractive Surgery annual meeting,San Diego,CA,3-7 May 2019.
48、 MARFURT C F,COX J,DEEK S,et al.Anatomy of the human corneal innervation[J].Exp Eye Res,2010,90(4):478-492. MARFURT C F,COX J,DEEK S,et al.Anatomy of the human corneal innervation[J].Exp Eye Res,2010,90(4):478-492.
49、 KIM J H,CHUNG J L,KANG S Y,et al.Change in corneal sensitivity and corneal nerve after cataract surgery[J].Cornea,2009,28(11):S20-S25. KIM J H,CHUNG J L,KANG S Y,et al.Change in corneal sensitivity and corneal nerve after cataract surgery[J].Cornea,2009,28(11):S20-S25.
50、 KHANAL S,TOMLINSON A,ESAKOWITZ L,et al.Changes in corneal sensitivity and tear physiology after phacoemulsification[J].Ophthalmic Physiol Opt,2008,28(2):127-134. KHANAL S,TOMLINSON A,ESAKOWITZ L,et al.Changes in corneal sensitivity and tear physiology after phacoemulsification[J].Ophthalmic Physiol Opt,2008,28(2):127-134.
51、 KOHLHAAS M.Corneal sensation after cataract and refractive surgery[J].J Cataract Refract Surg,1998,24(10):1399-1409. KOHLHAAS M.Corneal sensation after cataract and refractive surgery[J].J Cataract Refract Surg,1998,24(10):1399-1409.
52、 JOHN T.Corneal sensation after small incision,sutureless,one-handed phacoemulsification[J].J Cataract Refract Surg,1995,21(4):425-428. JOHN T.Corneal sensation after small incision,sutureless,one-handed phacoemulsification[J].J Cataract Refract Surg,1995,21(4):425-428.
53、 LYNE A.Corneal sensitivity after surgery[J].Trans Ophthalmol Soc U K,1982,102(pt.2):302-305. LYNE A.Corneal sensitivity after surgery[J].Trans Ophthalmol Soc U K,1982,102(pt.2):302-305.
54、 STARR C E,GUPTA P K,FARID M,et al.An algorithm for the preoperative diagnosis and treatment of ocular surface disorders[J].J Cataract Refract Surg,2019,45(5):669-684. STARR C E,GUPTA P K,FARID M,et al.An algorithm for the preoperative diagnosis and treatment of ocular surface disorders[J].J Cataract Refract Surg,2019,45(5):669-684.
55、 TRATTLER W B,MAJMUDAR P A,DONNENFELD E D,et al.The prospective health assessment of cataract patients’ ocular surface(PHACO)study:The effect of dry eye[J].Clin Ophthalmol,2017(11):1423-1430. TRATTLER W B,MAJMUDAR P A,DONNENFELD E D,et al.The prospective health assessment of cataract patients’ ocular surface(PHACO)study:The effect of dry eye[J].Clin Ophthalmol,2017(11):1423-1430.
56、 GUPTA P K,DRINKWATER O J,VANDUSEN K W,et al.Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation[J].J Cataract Refract Surg,2018(44):1090-1096. GUPTA P K,DRINKWATER O J,VANDUSEN K W,et al.Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation[J].J Cataract Refract Surg,2018(44):1090-1096.
57、 CETINKAYA S,MESTAN E,ACIR N O,et al.The course of dry eye after phacoemulsification surgery[J].BMC Ophthalmol,2015,15(1):68. CETINKAYA S,MESTAN E,ACIR N O,et al.The course of dry eye after phacoemulsification surgery[J].BMC Ophthalmol,2015,15(1):68.
58、 KOHLI P,ARYA S K,RAI A,et al.Changes in ocular surface status after phacoemulsification in patients with senile cataract[J].Int Ophthalmol,2018,39(6):1345-1353. KOHLI P,ARYA S K,RAI A,et al.Changes in ocular surface status after phacoemulsification in patients with senile cataract[J].Int Ophthalmol,2018,39(6):1345-1353.
59、 ZHANG K,ZHAO L,ZHU C,et al.The effect of diabetes on corneal endothelium:a meta-analysis[J].BMC Ophthalmol,2021,21(1):78. ZHANG K,ZHAO L,ZHU C,et al.The effect of diabetes on corneal endothelium:a meta-analysis[J].BMC Ophthalmol,2021,21(1):78.
60、 MIURA M,INOMATA T,NAKAMURA M,et al.Prevalence and characteristics of dry eye disease after cataract surgery:A systematic review and meta-analysis[J].Ophthalmol Ther,2022,11(4):1309-1332. MIURA M,INOMATA T,NAKAMURA M,et al.Prevalence and characteristics of dry eye disease after cataract surgery:A systematic review and meta-analysis[J].Ophthalmol Ther,2022,11(4):1309-1332.
61、 IGLESIAS E,SAJNANI R,LEVITT R C,et al.Epidemiology of persistent dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(7):893-898. IGLESIAS E,SAJNANI R,LEVITT R C,et al.Epidemiology of persistent dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(7):893-898.
62、 CHUANG J,SHIH K C,CHAN T,et al.Preoperative optimization of ocular surface disease before cataract surgery[J].Journal of Cataract and Refract Surg,2017,43(12):1596-1607. CHUANG J,SHIH K C,CHAN T,et al.Preoperative optimization of ocular surface disease before cataract surgery[J].Journal of Cataract and Refract Surg,2017,43(12):1596-1607.
63、 CHOI Y J,PARK S Y,JUN I,et al.Perioperative ocular parameters associated with persistent dry eye symptoms after cataract surgery[J].Cornea,2018,37(6):734-739. CHOI Y J,PARK S Y,JUN I,et al.Perioperative ocular parameters associated with persistent dry eye symptoms after cataract surgery[J].Cornea,2018,37(6):734-739.
64、 DASGUPTA S,GUPTA R.The course of dry eye following phacoemulsification and manual-SICS:a prospective study based on Indian scenario[J].Int Eye Sci,2016,16(10):17891794. DASGUPTA S,GUPTA R.The course of dry eye following phacoemulsification and manual-SICS:a prospective study based on Indian scenario[J].Int Eye Sci,2016,16(10):17891794.
65、 MIYAKE K,YOKOI N.Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye:A multicenter prospective randomized study[J].Clin Ophthalmol,2017(11):529-540. MIYAKE K,YOKOI N.Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye:A multicenter prospective randomized study[J].Clin Ophthalmol,2017(11):529-540.
66、 VEHOF J S,SMITT-KAMMINGA N,NIBOURG S A,et al.Predictors of discordance between symptoms and signs in dry eye disease[J].Ophthalmology,2016(124):280-286. VEHOF J S,SMITT-KAMMINGA N,NIBOURG S A,et al.Predictors of discordance between symptoms and signs in dry eye disease[J].Ophthalmology,2016(124):280-286.
67、 SONG P,SUN Z,REN S,et al.Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery:A prospective,randomized clinical trial[J].Biomed Res Int,2019(2019):2737968. SONG P,SUN Z,REN S,et al.Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery:A prospective,randomized clinical trial[J].Biomed Res Int,2019(2019):2737968.
68、 BARTLETT J D,KEITH M S,SUDHARSHAN L,et al.Associations between signs and symptoms of dry eye disease:A systematic review[J].Clin Ophthalmol,2015(9):1719-1730. BARTLETT J D,KEITH M S,SUDHARSHAN L,et al.Associations between signs and symptoms of dry eye disease:A systematic review[J].Clin Ophthalmol,2015(9):1719-1730.
69、 CREUZOT-GARCHER C,LAFONTAINE P O,GUALINO O,et al.Etude des atteintes de la surface oculaire chez les patients diabétiques [Study of ocular surface involvement in diabetic patients][J].J Fr Ophtalmol,2005,28(6):583-588. CREUZOT-GARCHER C,LAFONTAINE P O,GUALINO O,et al.Etude des atteintes de la surface oculaire chez les patients diabétiques [Study of ocular surface involvement in diabetic patients][J].J Fr Ophtalmol,2005,28(6):583-588.
70、 LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104. LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104.
71、 O’DONNELL C,EFRON N.Diabetes and contact lens wear[J].Clin Exp Optom,2012,95(3):328-337. O’DONNELL C,EFRON N.Diabetes and contact lens wear[J].Clin Exp Optom,2012,95(3):328-337.
72、 DEMILL D L,HUSSAIN M,POP-BUSUI R,et al.Ocular surface disease in patients with diabetic peripheral neuropathy[J].Br J Ophthalmol,2016,100(7):924-928. DEMILL D L,HUSSAIN M,POP-BUSUI R,et al.Ocular surface disease in patients with diabetic peripheral neuropathy[J].Br J Ophthalmol,2016,100(7):924-928.
73、 DOGRU M,KATAKAMI C,INOUE M.Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus[J].Ophthalmology,2001,108(3):586-592. DOGRU M,KATAKAMI C,INOUE M.Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus[J].Ophthalmology,2001,108(3):586-592.
74、 MISRA S L,PATEL D V,MCGHEE C N,et al.Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus[J].J Diabetes Res,2014(2014):848659. MISRA S L,PATEL D V,MCGHEE C N,et al.Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus[J].J Diabetes Res,2014(2014):848659.
75、 HAN S B,YANG H K,HYON J Y.Influence of diabetes mellitus on anterior segment of the eye[J].Clin Interv Aging,2018(14):53-63. HAN S B,YANG H K,HYON J Y.Influence of diabetes mellitus on anterior segment of the eye[J].Clin Interv Aging,2018(14):53-63.
76、 SHIMAZAKI J.Definition and diagnostic criteria of dry eye disease:historical overview and future directions[J].Investig Ophthalmol Vis Sci,2018,59(14):DES7-DES12. SHIMAZAKI J.Definition and diagnostic criteria of dry eye disease:historical overview and future directions[J].Investig Ophthalmol Vis Sci,2018,59(14):DES7-DES12.
77、 LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104. LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104.
78、 ACHTSIDIS V,ELEFTHERIADOU I,KOZANIDOU E,et al.Dry eye syndrome in subjects with diabetes and association with neuropathy[J].Diabetes Care,2014,37(10):e210-e211. ACHTSIDIS V,ELEFTHERIADOU I,KOZANIDOU E,et al.Dry eye syndrome in subjects with diabetes and association with neuropathy[J].Diabetes Care,2014,37(10):e210-e211.
79、 Koh S,Tung C,Inoue Y,et al.Effects of tear film dynamics on quality of vision[J].Br J Ophthalmol,2018,102(12):1615-1620. Koh S,Tung C,Inoue Y,et al.Effects of tear film dynamics on quality of vision[J].Br J Ophthalmol,2018,102(12):1615-1620.
80、 EPITROPOULOS A T,MATOSSIAN C,BERDY G J,et al.Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning[J].J Cataract Refract Surg,2015,41(8):1672-1677. EPITROPOULOS A T,MATOSSIAN C,BERDY G J,et al.Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning[J].J Cataract Refract Surg,2015,41(8):1672-1677.
81、 KOH S.Irregular astigmatism and higher-order aberrations in eyes with dry eye disease[J].Invest Ophthalmol Vis Sci,2018,59(14):DES36-DES40. KOH S.Irregular astigmatism and higher-order aberrations in eyes with dry eye disease[J].Invest Ophthalmol Vis Sci,2018,59(14):DES36-DES40.
82、 ISHRAT S,NEMA N,CHANDRAVANSHI S C L.Incidence and pattern of dry eye after cataract surgery[J].Saudi J Ophthalmol,2019,33(1):34-40. ISHRAT S,NEMA N,CHANDRAVANSHI S C L.Incidence and pattern of dry eye after cataract surgery[J].Saudi J Ophthalmol,2019,33(1):34-40.
83、 AMESCUA G,AKPEK E K,FARID M,et al.Blepharitis preferred practice pattern?[J].Ophthalmology,2019,126(1):P56-P93. AMESCUA G,AKPEK E K,FARID M,et al.Blepharitis preferred practice pattern?[J].Ophthalmology,2019,126(1):P56-P93.
84、 SHAO D,ZHU X,SUN W,et al.Effects of femtosecond laser-assisted cataract surgery on dry eye[J].Experim Therapeutic Med,2018,16(6):5073-5078. SHAO D,ZHU X,SUN W,et al.Effects of femtosecond laser-assisted cataract surgery on dry eye[J].Experim Therapeutic Med,2018,16(6):5073-5078.
85、 JU R H,CHEN Y,CHEN H S,et al.Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery[J].Int J Ophthalmol,2019,12(7):1122-1126. JU R H,CHEN Y,CHEN H S,et al.Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery[J].Int J Ophthalmol,2019,12(7):1122-1126.
86、 ROBERTS H W,WAGH V K,SULLIVAN D L,et al.A randomized controlled trial comparing femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery[J].J Cataract Refract Surg,2019,45(1):11-20. ROBERTS H W,WAGH V K,SULLIVAN D L,et al.A randomized controlled trial comparing femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery[J].J Cataract Refract Surg,2019,45(1):11-20.
87、 ROBERTS H W,DAY A C,O'BRART D P.Femtosecond laser-assisted cataract surgery:A review[J].Eur J Ophthalmol,2020,30(3):417-429. ROBERTS H W,DAY A C,O'BRART D P.Femtosecond laser-assisted cataract surgery:A review[J].Eur J Ophthalmol,2020,30(3):417-429.
88、 CRAIG J P,NICHOLS K K,AKPEK E K,et al.TFOS DEWS II definition and classification repor[J].Ocul Surf,2017,15(3):276-283. CRAIG J P,NICHOLS K K,AKPEK E K,et al.TFOS DEWS II definition and classification repor[J].Ocul Surf,2017,15(3):276-283.
89、 SAEEDI P,PETERSOHN I,SALPEA P,et al.Global and regional diabetes prevalence estimates for2019 and projections for 2030 and 2045:Results from the International Diabetes Federation Diabetes Atlas,9th edition[J].Diabetes Res Clin Pract,2019(157):107843. SAEEDI P,PETERSOHN I,SALPEA P,et al.Global and regional diabetes prevalence estimates for2019 and projections for 2030 and 2045:Results from the International Diabetes Federation Diabetes Atlas,9th edition[J].Diabetes Res Clin Pract,2019(157):107843.
